Feel good health Group

The Personal Hygiene Market forecast indicates sustained growth driven by increasing middle-class incomes, urbanisation, changing lifestyles, expanded e-commerce, and heightened awareness of personal-care hygiene in emerging regions. The growth of female workforce participation, aging populations requiring adult hygiene solutions, and wellness tourism further support demand. Global supply-chain resilience and brand diversification aid product availability across geographies and price-tiers.

Channel expansion plays a key role: online retail, subscription-box models, direct-to-customer platforms, and last-mile specialised distributors enable personalised hygiene solutions delivered to the home. Emerging markets in Asia-Pacific, Latin America, Middle East and Africa present the highest volume growth due to improving hygiene infrastructure and rising disposable income. The forecast suggests premium product tiers will grow fastest in developed markets, while value tiers will dominate in developing regions, driving overall category expansion.

FAQs

• Growth drivers? Rising incomes, urbanisation, female workforce, aging population.

• Channel trend? Shift to e-commerce, subscriptions and home delivery.

The Pharmacy Market forecast points to sustained growth underpinned by aging populations, increasing chronic disease prevalence, healthcare access expansion and rising demand for home-delivery pharmacy services. The transition toward self-care and preventive medicine increases OTC product uptake, while prescription-volume growth continues in speciality segments such as oncology, biologics, and rare-disease therapies. Licence renewals and regulatory updates drive pharmacies to invest in new service models and infrastructure.

Channel disruption plays a critical role: online pharmacy platforms, digital health integrations and same-day delivery logistics reshape competition. Established chains increasingly partner with e-commerce platforms or acquire digital start-ups to maintain relevance. Subscription-based medication ordering and automated refill programmes create recurring-revenue models and drive convenience. Forecast suggests that pharmacies offering blended physical-digital experiences will capture the fastest growth and retain customer loyalty.

FAQs

• Growth drivers? Aging demographics, chronic conditions, self-care demand.

• Channel trend? Shift from pharmacy counters to app-based and home delivery.

The Radiation Oncology Market forecast projects solid growth driven by increasing cancer burden globally, rising availability of advanced external-beam radiotherapy systems, expansion of proton- and heavy-ion-therapy centres, and broader accessibility in emerging markets. Uptake of hypofractionated protocols (fewer, higher-dose sessions) improves departmental efficiency and reduces total cost-of-care, making radiation oncology more attractive for providers. Furthermore, the need for retreatment of recurrent disease and precision-guided re-irradiation adds growth impetus to the services and technology side.

Emerging modalities such as magnetic-resonance-guided radiation therapy (MRgRT), adaptive radiotherapy, artificial-intelligence-assisted contouring and plan optimisation are set to accelerate adoption. The market forecast also anticipates increased leasing and financing models for capital equipment, expanding access in lower-and-middle-income countries. With improved reimbursement for advanced radiation treatments in many developed markets and expanding private-care capacity in emerging economies, the outlook remains robust across equipment, software and services sectors of radiation oncology.

FAQs

• Key driver? Rising cancer incidence and treatment…

The Biotechnology and Pharma Services Outsourcing Market forecast indicates strong expansion as pharmaceutical sponsors increasingly seek agility, global capacity, and digital capability. Growth is driven by diversification of drug modalities (biologics, ATMPs), increased complexity of regulatory expectations, global trials, and the realization of advanced therapeutic cost savings through outsourcing.

Providers that integrate AI-enabled analytics, cloud-based data platforms, global site networks, and scalable specialist teams are poised to capture the fastest growth segments.

In addition to volume growth, the outsourcing market will shift in service mix from standardized tasks towards high-value specialty services such as cell-gene CMC support, biosimilar development, regulatory-pathway consulting, real-world-evidence design, and market-access support. Vendors expanding geographic footprint to emerging-market pharma hubs, establishing multiphase service models, and adopting outcome-based contracting are expected to gain competitive edge. The forecast reflects a changing market where customization, platform integration, and strategic alignment with sponsor timelines matter most.

FAQs

• What drives growth? Modality…